Self-checkout: The Expansion of Machines

 

Shoppers may not like them, but self-checkout machines aren’t going anywhere soon. That market is growing and expanding beyond the grocery store.

The Bureau of Labor Statistics indicates the number of cashiers will fall by 10% over the next decade due to a competitive labor market and the expansion of self-checkout machines. Fewer cashiers mean more self-checkout lanes. Still, a survey of 1,000 shoppers in 2021 found that 67% experienced issues and errors using a self-checkout lane. It’s clear; customers don’t care for them, but retailers may have no choice but to continue increasing self-checkout to keep up with demand.

Customer satisfaction is an essential metric for retailers in all sectors. Retail must recognize the customer, and with self-checkout shortcomings prone to higher losses than traditional cashiers due to errors and theft, the industry must improve self-checkout technology to provide a better shopping experience.

James Prebills, Host of Point of Scale at MarketScale, examines the situation.

James’ Thoughts

“We’re seeing that retailers are continuing to adopt autonomous POS solutions or self-checkout machines, even though consumer sentiment with this shopping experience remains extremely low. If you were to survey consumers on how they feel about these self-checkout machines it’d be resoundingly negative.

They’re often buggy, they’re not immediately accessible interface experiences. But don’t be surprised if we continue to see this adoption at retailers rise and work with their POS solutions provider to create a more favorable experience. The main reason, in my opinion, we’re gonna continue to see this, is that the labor market, especially for hourly wage positions, remains incredibly competitive.

These autonomous solutions provide a way for retailers to have shorter waits at the checkout experience, even if there are buggy issues and problems around more flexible hourly scheduling. And that is still a more favorable experience than a long checkout line, just waiting for a human worker to do it.

Although this consumer sentiment around these solutions and their adoption remains extremely low, I think we’re gonna see it continue to rise going forward as well as the adoption of hybrid POS solutions, a checkout machine that can be manned by a person during peak hours, but then during lower hours, can be actually converted to an autonomous machine.”

Follow us on social media for the latest updates in B2B!

Image

Latest

Doable
Rethinking Leadership: Why “Doable” Might Be the Most Powerful Strategy in Education Today
April 3, 2026

At a time when educator burnout is rising and schools across the U.S. are facing ongoing teacher shortages, leaders are being forced to rethink what sustainable success actually looks like. Research shows that teacher attrition is closely tied to working conditions, job-related stress, and workload demands. As districts push for innovation, data-driven instruction, and…

Read More
Casey Brown
From Poverty to Pricing Power | Why Great Companies Undercharge
April 2, 2026

Casey Brown didn’t grow up thinking she would become an entrepreneur. She grew up in a blue-collar family where money was always tight — close enough to the edge that the fear of poverty shaped many of her early decisions. That fear led her into engineering, into corporate America, and eventually into a moment…

Read More
Nightingales Summit: Empowering the Next Generation of Nigerian Nurses
Nightingales Summit: Empowering the Next Generation of Nigerian Nurses
April 2, 2026

In this episode of Care Anywhere, host Lea Sims sits down with Nigerian nurse entrepreneur and advocate Obafemi Arowosegbe to discuss leadership, mentorship, and the future of nursing in Africa. While still a nursing student, Obafemi founded the Nightingale Summit, a growing conference designed to empower nursing students and early-career nurses with leadership skills,…

Read More
Oncology
From Denial to Access: Rethinking Oncology Care Through AI, Clinical Trials, and Patient-Centered Innovation
April 1, 2026

The rapid expansion of precision medicine, biologics, and targeted cancer therapies is transforming oncology—but it’s also overwhelming a system not built to keep pace. In the U.S., cancer drugs now account for some of the highest-cost treatments in healthcare, and with that has come a surge in prior authorization requirements and denials. Studies suggest physicians…

Read More